Please login to the form below

Not currently logged in

Deal Watch September 2016

Medius Deal Watch

Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up

How merging firms can manage culture change

Addressing the potential problems and finding the solutions

Choosing destiny

As our market transforms, firms must choose their new business model carefully

Market access improvements in Turkey

Optimising market research data in rare diseases

Helping to provide powerful insights into the burden of disease and the patient-caregiver experience


Scale & Strategy: Essential tools for transforming the commercial model

Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and

Immuno-oncology's evolution: implications for pharma market researche

Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached

Driving adoption of Commercial Analytic solutions

Driving adoption of Commercial Analytic solutionsMeasuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities

Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making

Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge


Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Revisiting Instagram for pharma

In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs

The one multichannel question you must ask

There is a question every marketer should ask when designing a multichannel communications strategy

Are reverse auctions the best way to procure marketing services?

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

KOL engagement: Blending accessibility with reliability

KOLs and healthcare professionals these days are much more likely to be digital natives, so KOL and HCP engagement should include a blend of visibility and quality content.

Featured jobs

Subscribe to our email news alerts


Add my company
Complete HealthVizion

Complete HealthVizion is a team outstanding healthcare communications experts who provide innovative strategic evidence based solutions through scientific and commercial...